DK0438234T3 - Antithrombinopløsning og anvendelse deraf - Google Patents

Antithrombinopløsning og anvendelse deraf

Info

Publication number
DK0438234T3
DK0438234T3 DK91300196.2T DK91300196T DK0438234T3 DK 0438234 T3 DK0438234 T3 DK 0438234T3 DK 91300196 T DK91300196 T DK 91300196T DK 0438234 T3 DK0438234 T3 DK 0438234T3
Authority
DK
Denmark
Prior art keywords
solution
antithrombin
orthopaedics
formations
patients
Prior art date
Application number
DK91300196.2T
Other languages
English (en)
Inventor
Kiyoshi Kita
Original Assignee
Kiyoshi Kita
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kiyoshi Kita filed Critical Kiyoshi Kita
Application granted granted Critical
Publication of DK0438234T3 publication Critical patent/DK0438234T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DK91300196.2T 1990-01-19 1991-01-11 Antithrombinopløsning og anvendelse deraf DK0438234T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008230A JPH03215430A (ja) 1990-01-19 1990-01-19 関節腔抗凝固剤

Publications (1)

Publication Number Publication Date
DK0438234T3 true DK0438234T3 (da) 1995-05-08

Family

ID=11687358

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91300196.2T DK0438234T3 (da) 1990-01-19 1991-01-11 Antithrombinopløsning og anvendelse deraf

Country Status (7)

Country Link
EP (1) EP0438234B1 (da)
JP (1) JPH03215430A (da)
AT (1) ATE120962T1 (da)
AU (1) AU636431B2 (da)
CA (1) CA2033680A1 (da)
DE (1) DE69108748T2 (da)
DK (1) DK0438234T3 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2146200T3 (es) * 1990-02-13 2000-08-01 Ethicon Inc Medicamentos inducidos peritonealmente.
WO1994022471A1 (en) * 1993-04-05 1994-10-13 The Green Cross Corporation Liquid antithrombin iii preparation and method of stabilizing the same
KR100236771B1 (ko) * 1997-04-01 2000-02-01 성재갑 히아루론산을 이용한 약물의 서방성 미세입자 제형
DE19937656A1 (de) * 1999-08-13 2001-02-15 Aventis Behring Gmbh Verwendung von Antithrombin III zur Prophylaxe und Therapie von Erkrankungen
DE10102048A1 (de) * 2001-01-17 2002-07-18 Aventis Behring Gmbh Antithrombin III gegen durch Angiogenese verursachte Krankheiten
US8273347B2 (en) 2003-05-13 2012-09-25 Depuy Spine, Inc. Autologous treatment of degenerated disc with cells
US7344716B2 (en) 2003-05-13 2008-03-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
US7553827B2 (en) 2003-08-13 2009-06-30 Depuy Spine, Inc. Transdiscal administration of cycline compounds
US7429378B2 (en) 2003-05-13 2008-09-30 Depuy Spine, Inc. Transdiscal administration of high affinity anti-MMP inhibitors
US8361467B2 (en) 2003-07-30 2013-01-29 Depuy Spine, Inc. Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
US8895540B2 (en) 2003-11-26 2014-11-25 DePuy Synthes Products, LLC Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
US8986696B2 (en) 2007-12-21 2015-03-24 Depuy Mitek, Inc. Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
AR087094A1 (es) * 2011-07-07 2014-02-12 Gtc Biotherapeutics Inc Formulaciones que estabilizan proteinas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3618638A1 (de) * 1986-06-03 1987-12-10 Behringwerke Ag Verfahren zur sekretion von proteinen aus hefen
US4749783A (en) * 1986-07-11 1988-06-07 Miles Laboratories, Inc. Viral inactivation and purification of active proteins
DE3624453A1 (de) * 1986-07-19 1988-01-28 Behringwerke Ag Verfahren zur herstellung von humanem antithrombin iii (atiii), dafuer geeignete vektoren und wirtszellen, so erhaltenes, biologisch aktives atiii und dieses enthaltende arzneimittel
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
US4877608A (en) * 1987-11-09 1989-10-31 Rorer Pharmaceutical Corporation Pharmaceutical plasma protein formulations in low ionic strength media

Also Published As

Publication number Publication date
ATE120962T1 (de) 1995-04-15
JPH03215430A (ja) 1991-09-20
AU6932691A (en) 1991-07-25
AU636431B2 (en) 1993-04-29
DE69108748T2 (de) 1995-09-14
EP0438234A1 (en) 1991-07-24
DE69108748D1 (de) 1995-05-18
CA2033680A1 (en) 1991-07-20
EP0438234B1 (en) 1995-04-12

Similar Documents

Publication Publication Date Title
DK0438234T3 (da) Antithrombinopløsning og anvendelse deraf
NO885109D0 (no) FremgangsmŸte og middel for Ÿ forhindre blodpropp.
CY1114734T1 (el) Φαρμακευτικες συνθεσεις και μεθοδοι χρησιμες για ρυθμιση αγγειογενεσης
CZ285522B6 (cs) Farmaceutický prostředek pro snížení koncentrace glukosy v krvi
DE3382458D1 (de) Haarwuchsmittel.
MX9203543A (es) Medicamento.
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
ATA91797A (de) Eine das vwf-propeptid enthaltende pharmazeutische präparation
IT9041503A0 (it) Dispositivo per la cura chirurgica dell'ametropia
DK0856312T3 (da) Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme
ATE126061T1 (de) Verwendung von lithium zur behandlung oder prophylaxe von molluscum contagiusum.
IE890580L (en) Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants
NO875055L (no) Injiserbare, bruksferdige opploesninger inneholdende et antitumor-antracyklin glykosid.
ES2094757T3 (es) Un factor megacariocitopoyetico.
ATE56147T1 (de) T-pa enthaltende medizinische zubereitung und deren verwendung.
SE8804640D0 (sv) Medicament comprising cyclolinopeptide a
DK0769945T3 (da) Brug af 2-phenyl-3-aroylbenzothiophenderivater til fremstilling af et medikament til behandling af knogler og knoglebrud
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
DK0711163T3 (da) Anvendelse af benzydamin i behandlingen af patologiske tilstande forårsaget af TNF
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy
GR77250B (da)
SE7806469L (sv) Antihypertensiva kompositioner
DE3778858D1 (de) 17-benzylspartein-derivate enthaltende positiv inotrop wirksame pharmazeutische zubereitungen.
IT1228977B (it) Apparecchio fisioterapico per la cura della sterilita' femminile accertata e per la dilatazione indolore del canale cervicale.